COc1ccc(Cn2c(=O)[nH]c3cc(C(=O)N4CCN(c5ccc(C(C)=O)cc5)CC4)ccc3c2=O)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?